AI Assistant
Blog
Pricing
Log In
Sign Up
OS6.2 Medulloblastoma recurrence: Improved survival with a metronomic and targeted antiangiogenesis therapy - experience in 18 patients
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
